Ignite Creation Date:
2024-05-06 @ 9:04 AM
Last Modification Date:
2024-10-26 @ 12:09 PM
Study NCT ID:
NCT02894398
Status:
COMPLETED
Last Update Posted:
2023-03-13
First Post:
2016-08-25
Brief Title:
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
Sponsor:
iOMEDICO AG
Organization:
iOMEDICO AG
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |
| Breast Cancer |
| Hormone Receptor Positive Tumor |